six-amino acid deletion basic fibroblast growth factor mitogenic activity plasminogen activator-inducing capacity recombinant deletion mutant acid form human basic fibroblast growth factor bFGF amino acid Lys-Asp-Pro-Lys-Arg-Leu Escherichia coli homogeneity heparin-Sepharose affinity chromatography presence equimolar concentration soluble heparin bFGF mutant potent bFGF cell proliferation normal transformed fetal bovine aortic endothelial cells adult bovine aortic endothelial cells NIH fibroblasts experimental conditions times efficient bFGF plasminogen activator PA production endothelial cells chromogenic PA assay SDS/PAGE zymography Northern blot analysis urokinase-type PA mRNA presence heparin plasma membrane receptors endothelial cells manner undistinguishable bFGF tyrosine phosphorylation pattern NIH cells data suggest PA-inducing activity bFGF functional domain differs mitogenic activity growth factor binding bFGF plasma membrane receptor sufficient urokinase-type PA production endothelial cells 